References
Bond AJ. Drug-induced behavioural disinhibition: incidence, mechanisms and therapeutic implications. CNS Drugs 1998; 9(1): 41–57
Healy D. The fluoxetine and suicide controversy: a review of the evidence. CNS Drugs 1994; 1: 223–31
Henry JA, Alexander CA, Sener EK. Relatively mortality from overdose of antidepressants. BMJ 1995; 310: 221–4
Edwards JG. Drug choice in depression: selective serotonin reuptake inhibitors or tricyclic antidepressants? CNS Drugs 1995; 4: 141–59
Rothschild AJ, Locke CA. Re-exposure to fluoxetine after serious suicide attempts by 3 patients: the role of akathisia. J Clin Psychiatry 1991; 52: 491–3
Wirshing WC, Van Putten T, Rosenberg J, et al. Fluoxetine, akathisia and suicidality: is there a causal connection? Arch Gen Psychiatry 1992; 49: 580–1
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62
Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382–9
Edwards IR. Who cares about pharmacovigilance? Eur J Clin Pharmacol 1997; 53: 83–8
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bond, A.J. Correspondence. Mol Diag Ther 9, 513–515 (1998). https://doi.org/10.2165/00023210-199809060-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00023210-199809060-00008